Orentas RJ - Search Results

1

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, Smith JP, Walker AJ, Kohler ME, Venkateshwara VR, Kaplan RN, Patterson GH, Fry TJ, Orentas RJ, Mackall CL. Long AH, et al. Among authors: orentas rj. Nat Med. 2015 Jun;21(6):581-90. doi: 10.1038/nm.3838. Epub 2015 May 4. Nat Med. 2015. PMID: 25939063 Free PMC article.

2

Suppression of anti-cancer immunity by regulatory T cells: back to the future.

Orentas RJ, Kohler ME, Johnson BD. Orentas RJ, et al. Semin Cancer Biol. 2006 Apr;16(2):137-49. doi: 10.1016/j.semcancer.2005.11.007. Epub 2006 Jan 11. Semin Cancer Biol. 2006. PMID: 16376101 Review.

3

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.

Zheng J, Kohler ME, Chen Q, Weber J, Khan J, Johnson BD, Orentas RJ. Zheng J, et al. Among authors: orentas rj. BMC Immunol. 2007 Mar 30;8:4. doi: 10.1186/1471-2172-8-4. BMC Immunol. 2007. PMID: 17397536 Free PMC article.

4

Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine.

Kohler ME, Hallett WH, Chen QR, Khan J, Johnson BD, Orentas RJ. Kohler ME, et al. Among authors: orentas rj. Cell Immunol. 2010;265(1):65-73. doi: 10.1016/j.cellimm.2010.07.004. Epub 2010 Jul 17. Cell Immunol. 2010. PMID: 20692654 Free PMC article.

5

Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data.

Kohler ME, Johnson BD, Palen K, Chen QR, Khan J, Orentas RJ. Kohler ME, et al. Among authors: orentas rj. Cancer Sci. 2010 Nov;101(11):2316-24. doi: 10.1111/j.1349-7006.2010.01694.x. Cancer Sci. 2010. PMID: 20718755 Free PMC article.

6

Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.

Meadors JL, Cui Y, Chen QR, Song YK, Khan J, Merlino G, Tsokos M, Orentas RJ, Mackall CL. Meadors JL, et al. Among authors: orentas rj. Pediatr Blood Cancer. 2011 Dec 1;57(6):921-9. doi: 10.1002/pbc.23048. Epub 2011 Apr 1. Pediatr Blood Cancer. 2011. PMID: 21462302 Free PMC article.

7

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer.

Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. Lee DW, et al. Clin Cancer Res. 2012 May 15;18(10):2780-90. doi: 10.1158/1078-0432.CCR-11-1920. Clin Cancer Res. 2012. PMID: 22589486 Free PMC article.

8

Immunotherapy targets in pediatric cancer.

Orentas RJ, Lee DW, Mackall C. Orentas RJ, et al. Front Oncol. 2012 Jan 30;2:3. doi: 10.3389/fonc.2012.00003. eCollection 2012. Front Oncol. 2012. PMID: 22645714 Free PMC article.

9

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ. Haso W, et al. Among authors: orentas rj. Blood. 2013 Feb 14;121(7):1165-74. doi: 10.1182/blood-2012-06-438002. Epub 2012 Dec 14. Blood. 2013. PMID: 23243285 Free PMC article.

10

Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers.

Orentas RJ, Yang JJ, Wen X, Wei JS, Mackall CL, Khan J. Orentas RJ, et al. Front Oncol. 2012 Dec 17;2:194. doi: 10.3389/fonc.2012.00194. eCollection 2012. Front Oncol. 2012. PMID: 23251904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters